Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China · Delayed Price · Currency is CNY 4.820
-0.210 (-4.17%)
Aug 21, 2026, 3:04 PM CST
SHE:002252 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,882 | 1,401 | 2,983 | 4,001 | 3,978 | 2,747 |
Short-Term Investments | 311.57 | 705.31 | - | - | - | - |
Trading Asset Securities | - | - | - | 197.41 | 237.77 | 219.38 |
Cash & Short-Term Investments | 2,194 | 2,107 | 2,983 | 4,198 | 4,216 | 2,966 |
Cash Growth | -45.67% | -29.37% | -28.95% | -0.41% | 42.11% | 33.90% |
Accounts Receivable | 2,389 | 2,223 | 1,810 | 774.08 | 915.44 | 649.52 |
Other Receivables | 78.17 | 92.81 | 3.31 | 9.81 | 2.02 | 1.21 |
Receivables | 2,467 | 2,316 | 1,814 | 783.88 | 917.46 | 650.73 |
Inventory | 5,551 | 5,366 | 4,293 | 3,667 | 3,269 | 3,173 |
Prepaid Expenses | - | 58.63 | 7.7 | 0.07 | 0.1 | 0.14 |
Other Current Assets | 191.9 | 103.93 | 160.9 | 25.92 | 71.41 | 81.69 |
Total Current Assets | 10,403 | 9,951 | 9,257 | 8,675 | 8,473 | 6,872 |
Property, Plant & Equipment | 2,658 | 2,662 | 1,922 | 1,453 | 1,282 | 1,279 |
Long-Term Investments | 15,087 | 16,004 | 16,777 | 16,177 | 15,702 | 13,878 |
Goodwill | 8,199 | 8,199 | 5,073 | 5,073 | 4,703 | 4,900 |
Other Intangible Assets | 731.27 | 732.55 | 485.01 | 233.85 | 175.49 | 163.18 |
Long-Term Deferred Tax Assets | 88.95 | 93.52 | 75.14 | 89.81 | 83.55 | 104.27 |
Long-Term Deferred Charges | 28.26 | 29.73 | 28.47 | 21.29 | 25.78 | 28.97 |
Other Long-Term Assets | 786.99 | 108.71 | 12.22 | 205.34 | 13 | 11.54 |
Total Assets | 37,983 | 37,781 | 33,631 | 31,928 | 30,458 | 27,237 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 621.36 | 343.02 | 1,076 | 1,651 | 1,130 | 956.29 |
Accrued Expenses | 100.52 | 362.09 | 341.83 | 289.17 | 275.36 | 234.64 |
Short-Term Debt | 1,280 | 1,309 | - | - | - | - |
Current Portion of Long-Term Debt | 117.02 | 107.93 | - | - | - | - |
Current Portion of Leases | - | 3.41 | 4.61 | 0.41 | 1.98 | 4.09 |
Current Income Taxes Payable | 79.59 | 45.35 | 25.94 | 94.57 | 91.03 | 53.53 |
Current Unearned Revenue | 7.5 | 3.54 | 4.69 | 22.64 | 91.76 | 28.69 |
Other Current Liabilities | 585.32 | 561.52 | 198.18 | 186.97 | 34.54 | 29.38 |
Total Current Liabilities | 2,792 | 2,736 | 1,652 | 2,245 | 1,625 | 1,307 |
Long-Term Debt | 2,547 | 2,473 | - | - | - | - |
Long-Term Leases | 9.53 | 10.39 | 12.99 | 1.49 | 1.85 | 4.16 |
Long-Term Unearned Revenue | 21.12 | 13.61 | 10.96 | 9.49 | 12.77 | 15.2 |
Long-Term Deferred Tax Liabilities | 43.21 | 44.89 | 14.82 | 16.02 | 5.34 | 6.44 |
Other Long-Term Liabilities | 46.9 | 46.9 | - | 7.06 | - | - |
Total Liabilities | 5,459 | 5,325 | 1,691 | 2,279 | 1,645 | 1,332 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 6,638 | 6,638 | 6,638 | 6,645 | 6,741 | 6,741 |
Additional Paid-In Capital | 14,044 | 14,042 | 14,058 | 13,805 | 14,560 | 14,560 |
Retained Earnings | 12,434 | 12,118 | 10,859 | 9,110 | 7,533 | 5,843 |
Treasury Stock | -522.95 | -522.95 | -77.18 | -182.92 | - | - |
Comprehensive Income & Other | -69.02 | 180.85 | 448.62 | 255.67 | -15.72 | -1,241 |
Total Common Equity | 32,524 | 32,456 | 31,926 | 29,634 | 28,819 | 25,902 |
Minority Interest | - | - | 14.46 | 15.86 | -5.37 | 1.72 |
Shareholders' Equity | 32,524 | 32,456 | 31,941 | 29,650 | 28,813 | 25,904 |
Total Liabilities & Equity | 37,983 | 37,781 | 33,631 | 31,928 | 30,458 | 27,237 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,954 | 3,904 | 17.59 | 1.91 | 3.82 | 8.25 |
Net Cash (Debt) | -1,760 | -1,798 | 2,965 | 4,196 | 4,212 | 2,958 |
Net Cash Growth | - | - | -29.34% | -0.36% | 42.38% | 34.00% |
Net Cash Per Share | -0.27 | -0.27 | 0.45 | 0.64 | 0.62 | 0.44 |
Filing Date Shares Outstanding | 6,580 | 6,557 | 6,617 | 6,605 | 6,741 | 6,741 |
Total Common Shares Outstanding | 6,580 | 6,557 | 6,617 | 6,605 | 6,741 | 6,741 |
Working Capital | 7,612 | 7,215 | 7,606 | 6,431 | 6,849 | 5,566 |
Book Value Per Share | 4.94 | 4.95 | 4.83 | 4.49 | 4.28 | 3.84 |
Tangible Book Value | 23,594 | 23,524 | 26,368 | 24,327 | 23,940 | 20,839 |
Tangible Book Value Per Share | 3.59 | 3.59 | 3.99 | 3.68 | 3.55 | 3.09 |
Buildings | - | 2,194 | 1,661 | 1,343 | 1,195 | 1,146 |
Machinery | - | 1,516 | 1,287 | 1,216 | 1,132 | 1,074 |
Construction In Progress | - | 393.01 | 289.21 | 134.03 | 74.19 | 26.89 |